Page last updated: 2024-08-25

6-amino-1-hydroxyhexane-1,1-diphosphonate and Osteoporotic Fractures

6-amino-1-hydroxyhexane-1,1-diphosphonate has been researched along with Osteoporotic Fractures in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Celli, L; Celli, M; D'Alfonso, Y; D'Eufemia, P; Febbo, A; Persiani, P; Turchetti, A; Zambrano, A1

Other Studies

1 other study(ies) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Osteoporotic Fractures

ArticleYear
Clinical and biochemical response to neridronate treatment in a patient with osteoporosis-pseudoglioma syndrome (OPPG).
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2017, Volume: 28, Issue:11

    Topics: Adolescent; Bone Density Conservation Agents; Diphosphonates; Humans; Low Density Lipoprotein Receptor-Related Protein-5; Male; Mutation; Osteogenesis Imperfecta; Osteoporotic Fractures; Radiography; Spinal Fractures

2017